Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes

被引:37
作者
Hanagata, Nobutaka [1 ,2 ]
Li, Xianglan [1 ]
机构
[1] Natl Inst Mat Sci, Interdisciplinary Lab Nanoscale Sci & Technol, Tsukuba, Ibaraki 3050047, Japan
[2] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan
关键词
IFITM5; FKBP11; Osteoblasts; Tetraspanins; Interferon-induced genes; SIGNAL-TRANSDUCTION; CYTOPLASMIC DOMAIN; B-LYMPHOCYTES; CELL-GROWTH; RECEPTOR; LEU-13; CD19; KINASE; MOUSE; LRG-47;
D O I
10.1016/j.bbrc.2011.04.136
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteoblasts are rich in interferon-inducible transmembrane protein 5 (IFITM5), the expression of which peaks around the early mineralization stage. This membrane protein directly associates with FK506 binding protein 11 (FKBP11). To examine the molecular function of IFITM5, we analyzed the protein interaction network around IFITM5-FKBP11. We found that FKBP11 was associated with CD81, which interacts with prostaglandin F2 receptor negative regulator (FPRP) and CD9; cumulatively, these associations result in the formation of a FKBP11-CD81-[FPRP/CD9] complex. However, CD9 dissociated from the complex following expression of Ifitm5, which also led to osteoblast-specific increased expression of 5 interferon-induced genes: bone marrow stromal cell antigen 2 (Bst2), interferon inducible protein 1 (Irgm), interferon-induced protein with tetratricopeptide repeats 3 (Ifit3), b(2)-microglobulin (B2m), and MHC (A.CA/J(H-2K-f) class I antigen gene. Induction of these genes likely resulted from dissociation of CD9 from the FKBP11-CD81-[FPRP/CD9] complex. Cumulatively, these results suggest that IFITM5 is involved not only in bone formation, but also in immune system activity. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:378 / 384
页数:7
相关论文
共 37 条
[1]   Bone marrow stromal cell antigen 2 is a specific marker of type IIFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation [J].
Blasius, Amanda L. ;
Giurisato, Emanuele ;
Celia, Marina ;
Schreiber, Robert D. ;
Shaw, Andrey S. ;
Colonna, Marco .
JOURNAL OF IMMUNOLOGY, 2006, 177 (05) :3260-3265
[2]  
BRADBURY LE, 1992, J IMMUNOL, V149, P2841
[3]  
BRADBURY LE, 1993, J IMMUNOL, V151, P2915
[4]   The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus [J].
Brass, Abraham L. ;
Huang, I-Chueh ;
Benita, Yair ;
John, Sinu P. ;
Krishnan, Manoj N. ;
Feeley, Eric M. ;
Ryan, Bethany J. ;
Weyer, Jessica L. ;
van der Weyden, Louise ;
Fikrig, Erol ;
Adams, David J. ;
Xavier, Ramnik J. ;
Farzan, Michael ;
Elledge, Stephen J. .
CELL, 2009, 139 (07) :1243-1254
[5]  
CALUPNY NJ, 1995, EUR J IMMUNOL, V25, P2978
[6]   The major CD9 and CD81 molecular partner - Identification and characterization of the complexes [J].
Charrin, S ;
Le Naour, F ;
Oualid, M ;
Billard, M ;
Faure, G ;
Hanash, SM ;
Boucheix, C ;
Rubinstein, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :14329-14337
[7]   EXPRESSION CLONING OF AN INTERFERON-INDUCIBLE 17-KDA MEMBRANE-PROTEIN IMPLICATED IN THE CONTROL OF CELL-GROWTH [J].
DEBLANDRE, GA ;
MARINX, OP ;
EVANS, SS ;
MAJJAJ, S ;
LEO, O ;
CAPUT, D ;
HUEZ, GA ;
WATHELET, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23860-23866
[8]  
EVANS SS, 1993, J IMMUNOL, V150, P736
[9]  
EVANS SS, 1990, BLOOD, V76, P2583
[10]  
Frey M, 1997, J IMMUNOL, V158, P5424